Clinical factors associated with hepatitis B screening and vaccination in high-risk adults

Table 3 High-risk medical conditions or activities

	Screening cohort				Vaccination cohort
High risk condition	Entire screening cohort (n = 999)	Screened for HBV (n = 556)	Not screened for HBV (n = 443)	P-value	Entire vaccination cohort (n = 556)	Vaccinated against HBV (n = 242)	Not vaccinated against HBV (n = 314)	P-value
Intravenous drug use	1.9%	0.9%	3.2%	0.018	0.9%	1.2%	0.6%	0.769
Men who have sex with Men	5.0%	4.0%	6.3%	0.120	4.0%	5.8%	2.5%	0.085
Chronic kidney disease	48.1%	64.6%	27.5%	< 0.001	64.6%	73.1%	58.0%	< 0.001
End stage renal disease (dialysis)	41.3%	59.2%	19.0%	< 0.001	59.2%	69.0%	51.6%	< 0.001
Chronic liver disease	25.7%	26.4%	24.8%	0.614	26.4%	21.5%	30.3%	0.026
Alcohol hepatitis	3.2%	4.9%	1.1%	0.002	4.9%	2.9%	6.4%	0.091
Primary sclerosing cholangitis	0.5%	0.5%	0.5%	0.799	0.5%	0%	1.0%	0.347
Primary biliary cirrhosis	0.7%	0.2%	1.4%	0.067	0.2%	0%	0.3%	0.896
Cryptogenic liver	0.6%	0.7%	0.5%	0.895	0.7%	0.8%	0.6%	0.807
Hemochromatosis	0.2%	0%	0.5%	0.382	0%	0%	0%	n/a
Hepatitis C	10.3%	9.4%	11.5%	0.312	9.4%	8.9%	9.9%	0.799
Non-alcoholic fatty liver disease	10.1%	11.2%	8.8%	0.264	11.2%	7.9%	13.7%	0.042
Non-alcoholic steatohepatitis	1.6%	1.6%	1.6%	0.837	1.6%	0.8%	2.2%	0.337
Autoimmune hepatitis	0.7%	1.1	0.2%	0.221	1.1%	0.8%	1.3%	0.926
End stage liver disease (cirrhosis)	10.6%	12.8%	7.9%	0.017	12.8%	9.5%	15.3%	0.058
Human immunodeficiency virus	14.3%	7.9%	22.3%	< 0.001	7.9%	9.9%	6.4%	0.168
High risk sexual behavior	22.5%	20.5%	25.1%	0.102	20.5%	23.6%	18.2%	0.145
Diabetes mellitus	46.8%	43.0%	51.7%	0.007	43.0%	37.2%	47.5%	0.019

HBV: Hepatitis B virus.